schizandrin b has been researched along with probenecid in 1 studies
| Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (probenecid) | Trials (probenecid) | Recent Studies (post-2010) (probenecid) |
|---|---|---|---|---|---|
| 321 | 1 | 218 | 3,664 | 292 | 375 |
| Protein | Taxonomy | schizandrin b (IC50) | probenecid (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 8 | Mus musculus (house mouse) | 3.02 | |
| Solute carrier family 22 member 6 | Homo sapiens (human) | 6.85 | |
| Solute carrier family 22 member 8 | Homo sapiens (human) | 6.965 | |
| Solute carrier family 22 member 8 | Rattus norvegicus (Norway rat) | 6.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, X; Lu, Q; Pan, Q; Sun, M; Xu, X | 1 |
1 other study(ies) available for schizandrin b and probenecid
| Article | Year |
|---|---|
Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclooctanes; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Lignans; Molecular Structure; Multidrug Resistance-Associated Proteins; Polycyclic Compounds; Probenecid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2007 |